Wen Y, Fang S, Yang J, Wang H, Jiao Y, Wang N, Wei Y, Wang L, Dou L
Medical School of Chinese PLA, Beijing 100853, China.
Department of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2022 May 20;42(5):690-697. doi: 10.12122/j.issn.1673-4254.2022.05.09.
To investigate the relationship between AML1-ETO (AE) fusion gene and intracellular N6-methyladenosine (m6A) modification pattern in t(8;21) acute myeloid leukemia (AML).
RNA m6A sequencing was performed in SKNO-1 and AE knockdown SKNO-1 (SKNO-1 siAE) cells using RNA-protein co-immunoprecipitation and high-throughput sequencing (methylated RNA immunoprecipitation sequencing, MeRIP-Seq) to analyze the changes in m6A modification of the entire transcriptome. Transcriptome sequencing (RNA-seq) was performed using high-throughput sequencing. The differentially modified mRNAs were further functionally annotated by Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. The changes in m6A-related enzyme expressions were detected using real-time PCR.
A total of 26 441 genes were identified in AE knockdown AML cells and AE-expressing cells, containing 72 036 m6A peaks. AE knockdown caused a reduction of the number of intracellular m6A peaks from 37 042 to 34 994, among which 1278 m6A peaks were significantly elevated and 1225 were significantly decreased; 1316 genes with newly emerged m6A modification were detected and 1830 genes lost m6A modification after AE knockdown. The differential peaks were mainly enriched in pathways involving cancer and human T-lymphocytic leukemia virus I. RNA-seq results showed that 2483 genes were up-regulated and 3913 genes were down-regulated after AE knockdown. The combined analysis of MeRIP-Seq and RNA-Seq results revealed relatively high expression levels of m6A-modified genes as compared with the genes without m6A modification (SKNO-1: 0.6116±1.263 2.010±1.655, < 0.0001; SKNO-1 siAE: 0.5528±1.257 2.067±1.686, < 0.0001). The m6A modified genes located in the 3'UTR or 5 'UTR had significantly higher expression levels than those located in exonic regions (SKNO-1: 2.177± 1.633 1.333 ± 1.470 2.449 ± 1.651, < 0.0001; SKNO-1 siAE: 2.304 ± 1.671 1.336 ± 1.522 2.394 ± 1.649, < 0.05). Analysis of RNA-seq data identified 3 m6A-related enzymes that showed significantly elevated mRNA expression after AE knockdown, namely WTAP, METTL14, and ALKBH5 ( < 0.05), but the results of real-time PCR showed that the expressions of WTAP and ALKBH5 were significantly increased while the expression of METTL14 was lowered after AE knockdown ( < 0.05).
AE knockdown results in differential expressions of m6A-associated enzymes, suggesting that the AE fusion gene regulates the expression of one or more m6A-associated enzymes to control cellular methylation levels.
探讨t(8;21)急性髓系白血病(AML)中AML1-ETO(AE)融合基因与细胞内N6-甲基腺苷(m6A)修饰模式之间的关系。
利用RNA-蛋白质免疫共沉淀和高通量测序(甲基化RNA免疫沉淀测序,MeRIP-Seq)技术,对SKNO-1细胞和AE基因敲低的SKNO-1细胞(SKNO-1 siAE)进行RNA m6A测序,以分析整个转录组m6A修饰的变化情况。采用高通量测序技术进行转录组测序(RNA-seq)。通过基因本体论(GO)分析和京都基因与基因组百科全书(KEGG)通路富集分析,对差异修饰的mRNA进行进一步的功能注释。采用实时荧光定量PCR检测m6A相关酶表达的变化。
在AE基因敲低的AML细胞和表达AE的细胞中总共鉴定出26441个基因,包含72036个m6A峰。AE基因敲低导致细胞内m6A峰数量从37042个减少至34994个,其中1278个m6A峰显著升高,1225个显著降低;检测到1316个出现新m6A修饰的基因,AE基因敲低后1830个基因失去m6A修饰。差异峰主要富集在涉及癌症和人类T淋巴细胞白血病病毒I的通路中。RNA-seq结果显示,AE基因敲低后2483个基因上调,3913个基因下调。MeRIP-Seq和RNA-Seq结果的联合分析显示,与未进行m6A修饰的基因相比,m6A修饰的基因表达水平相对较高(SKNO-1:0.6116±1.263对2.010±1.655,P<0.0001;SKNO-1 siAE:0.5528±1.257对2.067±1.686,P<0.0001)。位于3'UTR或5'UTR的m6A修饰基因的表达水平显著高于位于外显子区域的基因(SKNO-1:2.177±1.633对1.333±1.470对2.449±1.651,P<0.0001;SKNO-1 siAE:2.304±1.671对1.336±1.522对2.394±1.649,P<0.05)。对RNA-seq数据的分析确定了3种m6A相关酶,其在AE基因敲低后mRNA表达显著升高,即WTAP、METTL14和ALKBH5(P<0.05),但实时荧光定量PCR结果显示,AE基因敲低后WTAP和ALKBH5的表达显著增加,而METTL14的表达降低(P<0.05)。
AE基因敲低导致m6A相关酶的差异表达,提示AE融合基因通过调节一种或多种m6A相关酶的表达来控制细胞甲基化水平。